SR9009 Magnus Pharmaceuticals at a Glance
SR9009 is a Rev-Erbα nuclear receptor agonist that has garnered significant attention in metabolic research applications. This compound, manufactured by Magnus Pharmaceuticals, represents a sophisticated tool for investigating circadian rhythm modulation and cellular energy metabolism in laboratory settings. Unlike traditional selective androgen receptor modulators available through Stroid UK Shop, SR9009 operates through an entirely different mechanism, targeting the Rev-Erbα pathway to influence metabolic gene expression. Research teams examining metabolic syndrome models frequently investigate SR9009 alongside compounds from our stenabolic research category to understand its unique properties in cellular metabolism studies.
Laboratory Applications
In preclinical research models, SR9009 has been extensively studied for its effects on mitochondrial biogenesis, lipid metabolism regulation, and circadian clock gene expression. The compound demonstrates particular utility in studies examining metabolic dysfunction, where researchers evaluate its influence on fatty acid oxidation pathways and energy expenditure mechanisms. Laboratory investigations have explored SR9009’s potential in circadian biology research, examining how Rev-Erbα agonism affects the molecular clock machinery in various tissue types. Research teams often compare SR9009’s metabolic effects with other investigational compounds from our SARMs collection to understand tissue-specific metabolic responses. Studies examining mitochondrial function frequently incorporate SR9009 to investigate its role in cellular respiration and oxidative metabolism, particularly in muscle tissue research models.
Specification Data
| Parameter | Specification |
|---|---|
| CAS Number | 1379686-30-2 |
| Molecular Formula | C₂₀H₂₄ClN₃O₄S |
| Molecular Weight | 437.94 g/mol |
| Classification | Rev-Erbα agonist |
| Purity | Verify with supplier |
| Storage | Room temperature, dry conditions |
| Manufacturer | Magnus Pharmaceuticals |
Research teams studying metabolic pathways often investigate SR9009 alongside compounds from our peptides research range to examine synergistic effects on cellular energy metabolism and mitochondrial function in controlled laboratory environments.
Research Compliance
SR9009 Magnus Pharmaceuticals is manufactured exclusively for laboratory research purposes and in-vitro studies. This compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Research institutions must ensure proper handling protocols and maintain appropriate documentation for all investigational studies involving this compound.
